CONSOLIDATED STATEMENTS OF CASH FLOWS - USD ($) $ in Thousands	12 Months Ended
	Jun. 30, 2024	Jun. 30, 2023	Jun. 30, 2022
Cash flows from operating activities
Net income	$ 204,183	$ 126,867	$ 107,130
Adjustments to reconcile net income to net cash provided by operating activities:
Depreciation and amortization expense	109,683	110,358	97,914
Stock-based compensation expense	31,462	20,320	18,570
Deferred income taxes	2,890	(10,373)	1,190
Provision for credit losses	22,844	9,158	15,673
Amortization of fees on debt	1,640	1,597	1,573
Noncash operating lease expense	14,246	14,728	19,810
Other	849	(1,966)	9,949
Changes in assets and liabilities:
Accounts receivable	(32,056)	(54,908)	(57,501)
Inventories, prepaid expenses, deposits and other current and long-term assets	(8,877)	(19,389)	4,798
Accounts payable	(6,844)	(11,999)	11
Accrued liabilities	(16,556)	24,132	7,598
Accrued compensation and benefits	7,394	(15,473)	(7,465)
Operating lease liability	(14,990)	(12,243)	(20,742)
Deferred revenue and other liabilities	(37,071)	22,341	8,376
Net cash provided by operating activities	278,797	203,150	206,884
Cash flows from investing activities
Purchase of property and equipment	(2,270)	(4,336)	(9,748)
Capitalized software development costs	(40,653)	(44,973)	(42,191)
Capitalized curriculum development costs	(18,666)	(17,239)	(15,687)
Sale of other investments		60	5,261
Acquisition of assets		(1,409)
Other acquisitions, loans and investments, net of distributions	(5,196)	(1,652)	(3,899)
Proceeds from the maturity of marketable securities	204,487	91,879	40,163
Purchases of marketable securities	(277,573)	(140,570)	(84,657)
Net cash used in investing activities	(139,871)	(118,240)	(110,758)
Cash flows from financing activities
Repayments on finance lease obligations	(40,919)	(42,956)	(33,011)
Payments of contingent consideration		(7,024)
Payments of deferred purchase consideration			(22,858)
Proceeds from exercise of stock options		20	414
Repurchase of restricted stock for income tax withholding	(8,200)	(13,541)	(37,855)
Net cash used in financing activities	(49,119)	(63,501)	(93,310)
Net change in cash, cash equivalents and restricted cash	89,807	21,409	2,816
Cash, cash equivalents and restricted cash, beginning of period	410,807	389,398	386,582
Cash, cash equivalents and restricted cash, end of period	$ 500,614	$ 410,807	$ 389,398